Figure 2.

Success rates of tumor BRCA analysis by specimen type. Complete report: all exons of BRCA1 and BRCA2 sequenced; indeterminate report: ≥1 exon of BRCA1 and/or BRCA2 with low coverage depth or pathogenic or likely pathogenic variants below the limit of detection; failed report: unsuccessful BRCA analysis.